Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


SLAS Short Courses

01 Sep 2014 - 01 Sep 2014 - Manchester, UK



Bookmark and Share


The courses are complementary to the conference program; their objective is to educate people interested in these fields, providing an in-depth understanding of the topic and a comprehensive overview of the key techniques and recent developments. Delivered by distinguished faculty, these courses address a range of timely issues using real-world examples.

Later, in the conference, you can hear from researchers actively involved in these areas about their experiences and how the leading-edge is being explored !

The quality and educational content of SLAS short courses is well recognized and very well respected in our industry, and we are pleased to be partnering with SLAS to deliver these to you.

There is a charge to attend the short-courses, whilst the main Drug Discovery conference on Tue 2nd and Wed 3rd Sept remains free to attend ( please register for each separately ).

COURSE 1 : Introduction to Laboratory Automation

Jonathan Wingfield : AstraZeneca
Malcolm Crook : Peak Analysis & Automation

This introduction to automation course will provide a basic overview of when and how to successfully deploy automation within a laboratory environment. The course is tailored for managers who want to understand the strategic and tactical options for automation deployment. There will be an overview of the principles of automation architecture, infrastructure and laboratory informatics. There is no requirement for a working knowledge of, or experience with, automation.

View / download a full course summary.

COURSE 2 : High Content Screening: Instrumentation, Assay Development, Screening, Image and Data Analysis

Eberhard Krauß : ChemBioCon
Marc Bickle : Head HT-Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics

High-content screening is a powerful technology platform for implementing functional cell-based assays that allow truly multi-parametric analysis in the physiological context of intact cells. This course provides a state-of-the-art overview of the components of HCS (instrumentation, reagents, HC assay development, automated image analysis and multi-parametric data analysis, and data standards) together with some showcases of small molecule and RNAi high-content screens in industry and academia.

A demonstration will be given using the open source software CellProfiler how to analyze early endosomes in HeLa cells. Nuclei, cytosol and endosomes will be segmented and quantified. The resulting data will then be analyzed using the open source software KNIME. Parameters will be tested for normality, normalized and assembled into multiparametric profiles. The profiles will be quantified to estimate phenotypic strength and clustered to determine phenotypes. Both the slides describing the analysis and the pipelines will be made available to course participants to allow them to recreate the workflow in their own laboratories.

View / download a full course summary.

COURSE 3 : Establishing Cell-Based Assays and Implementing 3D Culture Models for screening and drug testing

Terry Riss : Senior Product Specialist, Cell Health, Promega Corporation
Jens Kelm : Insphero

This course will describe developing standard procedures for handling cultured cells to set up cell-based assays, describe techniques for measuring cell health and the mechanisms leading to cytotoxicity, and provide an overview of recent technological advances in 3D culture technologies that enable automation-compatible drug testing with more predictive and biologically relevant assays. Case studies will be presented which provide examples of using 3D model systems for screening and drug testing.

View / download a full course summary.



Further information
Scientific News
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
Can Gender Play A Role In Determining Cancer Treatment Choices?
MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!